Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories

Journal of Clinical Pathology

Volumn 56, Issue 9, 2003, Pages 687-689

  Piens, M A ^b   Perry, J D ^c   Raberin, H ^d   Parant, F ^a   Freydiere A M ^a  

^a HÔPITAL DEBROUSSE   (France)

^b Lab de Parasitol Mycologie Med   (France)

^c FREEMAN HOSPITAL   (United Kingdom)

^d HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE; CHROMOGENIC SUBSTRATE; TREHALASE;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CLINICAL LABORATORY; CONTROLLED STUDY; CULTURE MEDIUM; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; ENZYME ASSAY; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; LABORATORY DIAGNOSIS; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; TIME; YEAST;

EID: 0043264323     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.9.687     Document Type: Article

References (14)

1. Maquelin K, Choo-Smith LP, Endtz HP, et al. Rapid identification of Candida species by confocal raman microspectroscopy. J Clin Microbiol 2002;40:594-600.
2. Fenn JP, Billetdeaux E, Segal H, et al. Comparison of four methodologies for rapid and cost-effective identification of Candida glabrata. J Clin Microbiol 1999;37:3387-9.
3. Fidel PL, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinica disease with comparison to C albicans. Clin Microbiol Rev 1999;12:80-96.
4. Pfaller MA, Jones RN, Doern GV, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 2000 44:747-51.
5. Price MF, Larocco MT, Gentry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother 1994;38:1422-4.
6. Freydiere AM, Guinet R, Boiron P. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med Mycol 2001;39:9-33.
7. Fricker-Hidalgo H, Orenga S, Lebeau B, et al. Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species. J Clin Microbiol 2001;39:1647-9.
8. Willinger B, Hillowoth C, Selitsch B, et al. Performance of Candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida. J Clin Microbiol 2001;39:3793-5.
9. Baumgartner C, Freydiere AM, Gille Y. Direct identification and recognition of yeast species from clinical material by using Albicans ID and CHROMagar Candida plates. J Clin Microbiol 1996;34:454-6.
10. Freydiere AM. Evaluation of CHROMagar Candida plates. J Clin Microbiol 1996;34:2048.
11. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994;32:1923-9.
12. Parant F, Freydiere AM, Gille Y, et al. A "one minute" trehalase detection test for the identification of Candida glabrata. Journal of Medical Mycology 2001;11:26-31.
13. Freydiere AM, Parant F, Noel-Baron F, et al. Identification of Candida glabrata by a 30-second trehalase test. J Clin Microbiol 2002;40:3602-5.
14. Jabra-Rizk MA, Brenner TM, Romagnoli M, et al. Evaluation of a reformulated CHROMagar Candida. J Clin Microbiol 2001;39:2015-16.